These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34251141)

  • 1. Risk models for predicting in-hospital mortality from COVID-19 pneumonia in the elderly.
    López-Izquierdo R; Ruiz Albi T; Bermejo-Martín JF; Almansa R; Villafañe Sanz FV; Arroyo Olmedo L; Urbina Carrera CA; Sánchez Ramón S; Martín-Rodríguez F; Moreno Torrero F; Álvarez D; Del Campo Matía F
    Emergencias; 2021 Aug; 33(4):282-291. PubMed ID: 34251141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study.
    Lazar Neto F; Marino LO; Torres A; Cilloniz C; Meirelles Marchini JF; Garcia de Alencar JC; Palomeque A; Albacar N; Brandão Neto RA; Souza HP; Ranzani OT; ; ; ;
    Clin Microbiol Infect; 2021 Jul; 27(7):1037.e1-1037.e8. PubMed ID: 33813111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumonia severity indices predict prognosis in coronavirus disease-2019.
    Ucan ES; Ozgen Alpaydin A; Ozuygur SS; Ercan S; Unal B; Sayiner AA; Ergan B; Gokmen N; Savran Y; Kilinc O; Avkan Oguz V;
    Respir Med Res; 2021 May; 79():100826. PubMed ID: 33971434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic and stratified value of adrenomedullin in community acquired pneumonia patients in emergency department].
    Chen Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Feb; 26(2):115-9. PubMed ID: 24524403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia.
    Bradley J; Sbaih N; Chandler TR; Furmanek S; Ramirez JA; Cavallazzi R
    Chest; 2022 Apr; 161(4):927-936. PubMed ID: 34740594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charlson Comorbidity Index and other predictors of in-hospital mortality among adults with community-acquired pneumonia.
    Bahlis LF; Diogo LP; Fuchs SC
    J Bras Pneumol; 2021; 47(1):e20200257. PubMed ID: 33656092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of severity scores for predicting clinically relevant outcomes for patients hospitalized with community-acquired pneumonia.
    Yandiola PPE; Capelastegui A; Quintana J; Diez R; Gorordo I; Bilbao A; Zalacain R; Menendez R; Torres A
    Chest; 2009 Jun; 135(6):1572-1579. PubMed ID: 19141524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded A-DROP Score: A New Scoring System for the Prediction of Mortality in Hospitalized Patients with Community-acquired Pneumonia.
    Ahn JH; Choi EY
    Sci Rep; 2018 Oct; 8(1):14588. PubMed ID: 30275523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting mortality among older adults hospitalized for community-acquired pneumonia: an enhanced confusion, urea, respiratory rate and blood pressure score compared with pneumonia severity index.
    Abisheganaden J; Ding YY; Chong WF; Heng BH; Lim TK
    Respirology; 2012 Aug; 17(6):969-75. PubMed ID: 22574694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining a Frailty Index Based on Laboratory Data and Pneumonia Severity Assessments to Predict In-Hospital Outcomes in Older Adults with Community-Acquired Pneumonia.
    Zan YM; Zheng TP; Wang Y; Shao JF; Wang ZY; Zhao WH; Wu JQ; Xu W
    J Nutr Health Aging; 2023; 27(4):270-276. PubMed ID: 37170434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification and prediction value of procalcitonin and clinical severity scores for community-acquired pneumonia in ED.
    Zhou H; Guo S; Lan T; Ma S; Zhang F; Zhao Z
    Am J Emerg Med; 2018 Dec; 36(12):2155-2160. PubMed ID: 29691103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of severity classification of Chinese protocol, pneumonia severity index and CURB-65 in risk stratification and prognostic assessment of coronavirus disease 2019].
    Wang X; Hu ZW; Hu Y; Cheng Y; Zhang H; Li HC; Ma J; Wang GF; Zhao JP
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Oct; 43(10):834-838. PubMed ID: 32992436
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting pneumonia mortality using CURB-65, PSI, and patient characteristics in patients presenting to the emergency department of a comprehensive cancer center.
    Gonzalez C; Johnson T; Rolston K; Merriman K; Warneke C; Evans S
    Cancer Med; 2014 Aug; 3(4):962-70. PubMed ID: 24802800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Validation and Recalibration of the CURB-65 and PSI for Predicting 30-Day Mortality and Critical Care Intervention in Multiethnic Patients with COVID-19.
    Elmoheen A; Abdelhafez I; Salem W; Bahgat M; Elkandow A; Tarig A; Arshad N; Mohamed K; Al-Hitmi M; Saad M; Emam F; Taha S; Bashir K; Azad A
    Int J Infect Dis; 2021 Oct; 111():108-116. PubMed ID: 34416403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of PSI/PORT, CURB-65 and SCAP scoring system in COVID-19 pneumonia for prediction of disease severity and 14-day mortality.
    Anurag A; Preetam M
    Clin Respir J; 2021 May; 15(5):467-471. PubMed ID: 33417280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of risk scores in predicting mortality at 3, 6, and 12 months in patients diagnosed with community-acquired pneumonia.
    Tuta-Quintero E; Bastidas AR; Guerrón-Gómez G; Perna-Reyes I; Torres D; Garcia L; Villanueva J; Acuña C; Mikler E; Arcila J; Chavez N; Riviera A; Maldonado V; Galindo M; Fernández M; Schloss C; Reyes LF
    BMC Pulm Med; 2024 Jul; 24(1):334. PubMed ID: 38987754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and Prognostic Prediction in Very Elderly Patients With Severe Pneumonia.
    Baek MS; Park S; Choi JH; Kim CH; Hyun IG
    J Intensive Care Med; 2020 Dec; 35(12):1405-1410. PubMed ID: 30678533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP; Capelastegui A; Mar C; Bilbao A; Quintana JM; Diez R; Esteban C; Bereciartua E; Unanue U; Uranga A
    J Infect; 2015 May; 70(5):457-66. PubMed ID: 25499199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Sicilia-Bravo I; Palomo-de Los Reyes MJ; Cabezas-Martínez A; Laín-Terés N; Estebaran-Martín J; Lozano-Ancín A; Cuena-Boy R
    Enferm Infecc Microbiol Clin; 2014 Apr; 32(4):225-35. PubMed ID: 24182623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method to predict hospital mortality in severe community acquired pneumonia.
    Wang X; Jiao J; Wei R; Feng Y; Ma X; Li Y; Du Y
    Eur J Intern Med; 2017 May; 40():56-63. PubMed ID: 28320569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.